Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers

Novartis

Status and phase: Completed; Phase 4

Conditions: Dyslipidemia

Treatments: Drug: Fluvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00171262

CXUO320BES02

Details and patient eligibility

About

To analyze efficacy of fluvastatin on patients with chronic renal disease by analyzing certain inflammatory markers. In addition, tolerability and safety will also be evaluated in a Spanish population.

Enrollment: 120 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients > 18 years Patients that give their inform consent

Exclusion criteria

• Pregnant women Diabetic patients Treated with statins for the year prior to study inclusion Patients with contraindications listed in fluvastatin prescribing information

Other protocol-defined in and exclusion criteria may apply

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind